Article Information
- Received March 6, 1998
- Revision received June 23, 1998
- Accepted June 29, 1998
- First published September 15, 1998.
- Version of record published September 15, 1998.
Author Information
Author contributions
Disclosures
- Received March 6, 1998.
- Revision received June 23, 1998.
- Accepted June 29, 1998.
This work was supported by National Institutes of Health Grants NS23022 and NS33091 and National Multiple Sclerosis Society Grants RG2233 and RG2693. We thank Vance Handley for assistance in managing the transgenic lines and optimizing the lac Z staining, and Edwina Skinner and Lauren Cherman for assistance with tissue preparation. We also thank Dr. André M. Goffinet for providing us with reelin monoclonal antibody.
C.F.L. and T.M.P. contributed equally to this work.
Correspondence should be addressed to Dr. A. T. Campagnoni, MRRC/NPI, Room 47–448, University of California at Los Angeles, School of Medicine, 760 Westwood Plaza, Los Angeles, CA 90024.
Dr. Pribyl’s present address: Digital Gene Technologies, La Jolla, CA 92037.
Dr. Ellison’s present address: SmithKline Beecham Pharmaceuticals, King of Prussia, PA 19406.
Online Impact